Effect of screening on ovarian cancer mortality: the prostate, lung, colorectal and ovarian (PLCO) cancer screening randomized controlled trial

SS Buys, E Partridge, A Black, CC Johnson… - Jama, 2011 - jamanetwork.com
Context Screening for ovarian cancer with cancer antigen 125 (CA-125) and transvaginal
ultrasound has an unknown effect on mortality. Objective To evaluate the effect of screening …
被引用次数：1726 相关文章
[PDF] academia.edu

[PDF][PDF] Effect of Screening on Ovarian Cancer Mortality

SS Buys, E Partridge, A Black, CC Johnson… - JAMA, 2011 - academia.edu
Objective To evaluate the effect of screening for ovarian cancer on mortality in the Prostate,
Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Design, Setting, and …
[PDF] caregate.net

[PDF][PDF] Effect of Screening on Ovarian Cancer Mortality

SS Buys, E Partridge, A Black, CC Johnson… - JAMA, 2011 - phdres.caregate.net
Objective To evaluate the effect of screening for ovarian cancer on mortality in the Prostate,
Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Design, Setting, and …
[PDF] researchgate.net

[PDF][PDF] Effect of Screening on Ovarian Cancer Mortality

SS Buys, E Partridge, A Black, CC Johnson… - JAMA, 2011 - researchgate.net
Objective To evaluate the effect of screening for ovarian cancer on mortality in the Prostate,
Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Design, Setting, and …

[引用][C] Effect of Screening on Ovarian Cancer Mortality: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial

SS BUYS, E PARTRIDGE… - JAMA, the journal of …, 2011 - pascal-francis.inist.fr
Effect of Screening on Ovarian Cancer Mortality: The Prostate, Lung, Colorectal and Ovarian
(PLCO) Cancer Screening Randomized Controlled Trial CNRS Inist Pascal-Francis CNRS Pascal …

Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.

SS Buys, E Partridge, A Black, CC Johnson… - JAMA, 2011 - europepmc.org
Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO)
Cancer Screening Randomized Controlled Trial. - Abstract - Europe PMC Sign in | Create an …

Effect of screening on ovarian cancer mortality: The Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening randomized controlled trial

SS Buys, E Partridge, A Black, CC Johnson… - JAMA, 2011 - profiles.wustl.edu
Context: Screening for ovarian cancer with cancer antigen 125 (CA-125) and transvaginal
ultrasound has an unknown effect on mortality. Objective: To evaluate the effect of screening …

Effect of screening on ovarian cancer mortality: The Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening randomized controlled trial

SS Buys, E Partridge, A Black, CC Johnson… - JAMA, 2011 - experts.umn.edu
Context: Screening for ovarian cancer with cancer antigen 125 (CA-125) and transvaginal
ultrasound has an unknown effect on mortality. Objective: To evaluate the effect of screening …

Effect of Screening on Ovarian Cancer Mortality: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.

SS Buys, E Partridge, A Black… - JAMA: Journal of …, 2011 - search.ebscohost.com
This article discusses a study which reviewed the effect of screening for ovarian cancer with
cancer antigen 125 (CA-125) on mortality in the Prostate, Lung, Colorectal and Ovarian …

Effect of screening on ovarian cancer mortality. The Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening randomized controlled trial.

SS Buys, E Partridge, A Black, CC Johnson… - 2011 - cabidigitallibrary.org
Context: Screening for ovarian cancer with cancer antigen 125 (CA-125) and transvaginal
ultrasound has an unknown effect on mortality. Objective: To evaluate the effect of screening …